Target intelligence / Profile preview

Mucus layer in airway

Molecular classification
Other
01

Overview

The mucus layer in the airways is **not a single protein or receptor**, but rather a complex gel-like barrier composed majorly of the secreted polymeric mucins MUC5B and MUC5AC, water, salts, lipids, and a variety of defense proteins[1][2][5]. It plays a critical role in **trapping inhaled particles, allergens, and pathogens**, enabling their clearance from the lung by coordinated ciliary movement (mucociliary clearance)[5][6]. The thickness, hydration, and composition of the mucus layer, regulated by epithelial ion transport and mucin secretion, are crucial for lung defense and efficient mucus clearance[3][4]. Diseases such as cystic fibrosis, COPD, and asthma involve dysregulation of this layer, often leading to increased viscosity and impaired clearance[1][5][6]. Pharmacological interventions mostly target **the mucus layer itself** to alter its hydration or viscosity, not a single molecular target as usually implied by "therapeutic target" in drug development. Note: - This entity is **not a canonical drug target** such as a receptor, enzyme, or transporter. Instead, it is a complex extracellular hydrogel structure. - If your intent is to refer to a specific molecular component (like MUC5AC, MUC5B, or a particular ion channel), you should specify that molecular target. - "Mucus layer in airway" is a functional/anatomical structure rather than a discrete biochemical therapeutic target[1][5][6].

Other names
Airway mucusAirway mucus layerMucus gelAirway surface liquid (in some contexts)
02

Mechanism of action

Mucolysis (hydrating or breaking down mucus to reduce viscosity) - Enhancing mucociliary clearance - Reducing secretion or hypersecretion of mucins

03

Biological functions

Mechanical barrierMucociliary clearanceHost defensePathogen trappingLubricationHydration maintenance
04

Disease associations

InflammationInfectionObstructive lung disease (e.g., asthma, COPD)Cystic fibrosisOther
05

Safety considerations

Over-thinning may compromise barrier and increase pathogen invasionAirway dehydration may worsen mucus stasisIncreased risk of bleeding or irritation with excessive intervention
06

Interacting drugs

Dornase alfa (breaks down DNA in mucus)

4 more in the full profile.

07

Biomarkers

MUC5AC (major gel-forming mucin)MUC5B (major gel-forming mucin)Mucin protein concentration in sputumSputum viscosity/elastance measurements

Beyond the preview

Go deeper on Mucus layer in airway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucus layer in airway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call